Relativistic theory of elastic deformable astronomical bodies: perturbation equations in rotating spherical coordinates and junction conditions

In this paper, the dynamical equations and junction conditions at the interface between adjacent layers of different elastic properties for an elastic deformable astronomical body in the first post-Newtonian approximation of Einstein theory of gravity are discussed in both rotating Cartesian coordinates and rotating spherical coordinates. The unperturbed rotating body (the ground state) is described as uniformly rotating, stationary and axisymmetric configuration in an asymptotically flat space-time manifold. Deviations from the equilibrium configuration are described by means of a displacement field. In terms of the formalism of relativistic celestial mechanics developed by Damour, Soffel and Xu, and the framework established by Carter and Quintana the post Newtonian equations of the displacement field and the symmetric trace-free shear tensor are obtained. Corresponding post-Newtonian junction conditions at interfaces also the outer surface boundary conditions are presented. The PN junction condition is an extension of Wahr's one which is a Newtonian junction conditions without rotating.Comment: Revtex4, 14 page

Glaciovolcanic evidence for a polythermal Neogene East Antarctic Ice Sheet

A paradigm has existed for more than 30 years that the basal thermal regime of the East Antarctic Ice Sheet in Victoria Land made a fundamental transition from wet-based to cold-based either at ca. 14 Ma or after ca. 2.5 Ma. The basal thermal regime is important because it determines the potential for unstable behavior in an ice sheet. We have studied the environmental characteristics of subglacially erupted volcanic centers scattered along 800 km of the Ross Sea fl ank of the Transantarctic Mountains. The volcanoes preserve evidence for the coeval paleo-ice thicknesses and contain features diagnostic of both wet-based and cold-based ice conditions. By dating the sequences we are able to demonstrate that the basal thermal regime varied spatially and with time between ca. 12 Ma and present. It was polythermal overall and probably comprised a coarse temperature patchwork of frozen-bed and thawed-bed ice, similar to the East Antarctic Ice Sheet today. Thus, an important shift is required in the prevailing paradigm describing its temporal evolution

FÓRUM CIENTÍFICO DE ESTUDOS EM PACIENTES ESPECIAIS

A identificação e estudo de experiências e estratégias em serviços de saúde capacitam ao acadêmico o exercício e possibilidade de elaboração de planejamento em saúde em diferentes tipos populacionais. A atuação do acadêmico de odontologia junto ao paciente especial leva ao crescimento constante do interesse e conhecimentos pelos processos educativos em saúde bucal e da humanização do atendimento odontológico. O fórum científico de estudos em pacientes especiais possibilita aos acadêmicos e professores do curso de odontologia a aportunidade de aprimoramento técnico-cinetífico através da realização de pesquisa e debate sobre programas desenvolvidos pelo Ministério da saúde e a inserção do profissinal cirurgião-dentista nos mesmos. Para elaboração do artigo final e debate de apresentação são realizadas três oficinas de pesquisa na biblioteca central do Campus de Joaçaba. Após a confecção do artigo escrito e apresentação em formato power point, são realizadas 3 prévias da apresentação oral, com o intuito de debate, correções finais e treinamento de oratória. A apresentação final ocorre no formato de mesa redonda, com convidados de diferentes meios, alunos e professores do curso de odontologia. Cada semestre um novo tema é escolhido, dependendo da necessidade de se conhecer algum assunto ou programa específico do Ministério da Saúde. É um importante momento de troca de experiências e reflexões entre os acadêmicos e profissionais envolvidos, proporcionando uma aproximação com a comunidade e ao mesmo tempo contribuindo para a valorização profissional do cirurgião dentista.

An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia

Currently, there are no straightforward guidelines for the clinical and diagnostic management of hyperCKemia, a frequent and nonspecific presentation in muscle diseases. Therefore, we aimed to describe our diagnostic workflow for evaluating patients with this condition. Methods: We selected 83 asymptomatic or minimally symptomatic patients with persistent hyperCKemia for participation in this Italian multicenter study. Patients with facial involvement and distal or congenital myopathies were excluded, as were patients with suspected inflammatory myopathies or predominant respiratory or cardiac involvement. All patients underwent a neurological examination and nerve conduction and electromyography studies. The first step of the investigation included a screening for Pompe disease. We then evaluated the patients for myotonic dystrophy type II\u2013related CCTG expansion and excluded patients with copy number variations in the DMD gene. Subsequently, the undiagnosed patients were investigated using a target gene panel that included 20 genes associated with isolated hyperCKemia. Results: Using this approach, we established a definitive diagnosis in one third of the patients. The detection rate was higher in patients with severe hyperCKemia and abnormal electromyographic findings. Discussion: We have described our diagnostic workflow for isolated hyperCKemia, which is based on electrodiagnostic data, biochemical screening, and first-line genetic investigations, followed by successive targeted sequencing panels. Both clinical signs and electromyographic abnormalities are associated with increased diagnostic yields

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

open24noTafamidis is a transthyretin (TTR) stabilizer able to prevent TTR tetramer dissociation. There have been a few encouraging studies on Tafamidis efficacy in early-onset inherited transthyretin amyloidosis (ATTR) due to Val30Met mutation. However, less is known about its efficacy in later disease stages and in non-Val30Met mutations. We performed a multi-center observational study on symptomatic ATTR patients prescribed to receive Tafamidis. We followed up patients according to a standardized protocol including general medical, cardiological and neurological assessments at baseline and every 6 months up to 3 years. Sixty-one (42 males) patients were recruited. Only 28 % of enrolled subjects had the common Val30Met mutation, mean age of onset was remarkably late (59 years) and 18 % was in advanced disease stage at study entry. Tafamidis proved safe and well-tolerated. One-third of patients did not show significant progression along 36 months, independently from mutation type and disease stage. Neurological function worsened particularly in the first 6 months but progression slowed significantly thereafter. Autonomic function remained stable in 33 %, worsened in 56 % and improved in 10 %. Fifteen percent of patients showed cardiac disease progression and 30 % new onset of cardiomyopathy. Overall, Tafamidis was not able to prevent functional progression of the disease in 23 (43 %) subjects, including 16 patients who worsened in their walking ability and 12 patients who reached a higher NYHA score during the follow-up period. A higher mBMI at baseline was associated with better preservation of neurological function. In conclusion, neuropathy and cardiomyopathy progressed in a significant proportion of patients despite treatment. However, worsening of neurological function slowed after the first 6 months and also subjects with more advanced neuropathy, as well as patients with non-Val30Met mutation, benefited from treatment. Body weight preservation is an important favorable prognostic factor.openCortese, A.; Vita, G.; Luigetti, M.; Russo, M.; Bisogni, G.; Sabatelli, M.; Manganelli, F.; Santoro, L.; Cavallaro, T.; Fabrizi, G.M.; Schenone, A.; Grandis, M.; Gemelli, C.; Mauro, A.; Pradotto, L.G.; Gentile, L.; Stancanelli, C.; Lozza, A.; Perlini, S.; Piscosquito, G.; Calabrese, D.; Mazzeo, A.; Obici, L.; Pareyson, DCortese, Andrea; Vita, G.; Luigetti, M.; Russo, M.; Bisogni, G.; Sabatelli, M.; Manganelli, F.; Santoro, L.; Cavallaro, T.; Fabrizi, G. M.; Schenone, A.; Grandis, M.; Gemelli, C.; Mauro, A.; Pradotto, L. G.; Gentile, L.; Stancanelli, C.; Lozza, A.; Perlini, Stefano; Piscosquito, G.; Calabrese, D.; Mazzeo, A.; Obici, L.; Pareyson, D

ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with the Stat5b Pathway

ZFP36L1 negatively regulates erythroid differentiation of human hematopoietic progenitors by directly binding the 3′ UTR of Stat5b mRNA, thereby triggering its degradation. This study shows that posttranscriptional regulation is involved in the control of hematopoietic differentiation

Preparação e caracterização de um biocompósito obtido pela mistura de hidreto de titânio com nitrato de cálcio para implantes dentários

RESUMO Neste trabalho foram realizados estudos sobre a fabricação de um biocompósito à base de titânio para implantes dentários a partir da mistura de pó de hidreto de titânio (92%) com nitrato de cálcio (8% em volume). O pó de hidreto de titânio foi adicionado na solução aquosa de nitrato de cálcio, dissolvido por agitação mecânica, e em seguida os precursores foram misturados e dispersados/homogeneizados por ultrassom. Posteriormente, a mistura foi secada em evaporador rotativo, compactada com 600 MPa à temperatura ambiente, desmoldada e sinterizada em alto vácuo a 1200 oC durante 2 horas. Foi analisada a microestrutrura e fases formadas, as propriedades mecânicas, a rugosidade da superfície, a porosidade aberta, a molhabilidade da superfície e a citotoxicidade do biocompósito. As fases identificadas após a sinterização foram α-Ti e CaTiO3. O limite de resistência em compressão, o módulo de Young (E) e o ângulo de contato do biocompósito diminuíram significativamente com relação ao hidreto de titânio puro sinterizado nas mesmas condições. O limite médio de resistência em compressão do hidreto de titânio foi de 1794,67 MPa e do biocompósito foi de 481,36 MPa. O módulo de Young e o ângulo de contato do hidreto de titânio e do biocompósito foram de aproximadamente 112 GPa e 94 graus, e de 75 GPa e 83 graus, respectivamente. A rugosidade de superfície foi da mesma ordem de grandeza entre os materiais e ficou aproximadamente entre 1,4 e 1,5 µm (Ra) e 1,4 e 1,9 µm (Ra e Sa), medidas com rugosímetro de contato e com microscópio confocal a laser, respectivamente. A porosidade aberta do biocompósito sinterizado foi de aproximadamente três vezes maior do que aquela do hidreto de titânio sinterizado. Nos ensaios de citotoxicidade a porcentagem de células viáveis do biocompósito foi superior àquela do controle negativo e àquela do hidreto de titânio sinterizado

Role of MeCP2, DNA methylation, and HDACs in regulating synapse function

Over the past several years there has been intense effort to delineate the role of epigenetic factors, including methyl-CpG-binding protein 2, histone deacetylases, and DNA methyltransferases, in synaptic function. Studies from our group as well as others have shown that these key epigenetic mechanisms are critical regulators of synapse formation, maturation, as well as function. Although most studies have identified selective deficits in excitatory neurotransmission, the latest work has also uncovered deficits in inhibitory neurotransmission as well. Despite the rapid pace of advances, the exact synaptic mechanisms and gene targets that mediate these effects on neurotransmission remain unclear. Nevertheless, these findings not only open new avenues for understanding neuronal circuit abnormalities associated with neurodevelopmental disorders but also elucidate potential targets for addressing the pathophysiology of several intractable neuropsychiatric disorders